Detalhe da pesquisa
1.
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study.
Gynecol Oncol
; 166(2): 245-253, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835611
2.
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.
Ann Oncol
; 30(6): 1019, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30624581
3.
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.
Ann Oncol
; 25(7): 1428-1436, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24769640
4.
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.
Ann Oncol
; 25(3): 700-706, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24504441
5.
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada.
Curr Oncol
; 20(5): e371-87, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24155635
6.
Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.
Ann Oncol
; 22(12): 2582-2590, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406472
7.
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.
Breast Cancer Res Treat
; 123(1): 9-24, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20535542
8.
Adjusting for Treatment Crossover in A Trametinib Metastatic Melanoma Rct: Identifying the Appropriate Method.
Value Health
; 17(7): A577, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27201939
9.
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer.
Br J Cancer
; 99(5): 711-5, 2008 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18728660
10.
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer.
Br J Cancer
; 99(10): 1572-8, 2008 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19002178
11.
Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization.
Osteoporos Int
; 19(10): 1421-9, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18351427
12.
Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer.
Curr Med Res Opin
; 26(5): 1065-73, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20214527
13.
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
Curr Med Res Opin
; 23(10): 2517-29, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17825128
14.
Pharmacists' preferences for continuing education and certificate programs.
Ann Pharmacother
; 35(3): 289-99, 2001 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11261525
15.
Barriers and facilitators to providing common preventive screening services in managed care settings.
J Community Health
; 24(3): 229-47, 1999 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10399654
16.
Pharmacists and immunizations: a national survey.
J Am Pharm Assoc (Wash)
; 41(1): 32-45, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11216109
17.
Assessing managed care's role in promoting preventive care.
J Community Health
; 25(3): 225-40, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10868816
18.
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.
J Clin Pharm Ther
; 22(3): 207-15, 1997 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-9447476
19.
Obesity and health-related quality of life: a cross-sectional analysis of the US population.
Int J Obes Relat Metab Disord
; 27(10): 1227-32, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14513071